Tokyo Tape
Sign in
← Medinet

Quarterly report · Q3

2370.TEDINET S100P0C7
Period2021-10-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥470m2021-10-01 → 2022-06-30StandaloneNet sales
Revenue¥683m2020-10-01 → 2021-09-30StandaloneNet sales (5-year summary)
Revenue¥512m2020-10-01 → 2021-06-30StandaloneNet sales
Operating income−¥988m2021-10-01 → 2022-06-30StandaloneOperating income
Operating income−¥792m2020-10-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥984m2021-10-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥871m2020-10-01 → 2021-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥577m2020-10-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥985m2021-10-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥545m2020-10-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥989m2021-10-01 → 2022-06-30StandaloneProfit loss
Net income−¥843m2020-10-01 → 2021-09-30StandaloneNet income loss (5-year summary)
Net income−¥549m2020-10-01 → 2021-06-30StandaloneProfit loss
Total assets¥6.3bnat 2022-06-30StandaloneAssets
Total assets¥5.4bnat 2021-09-30StandaloneAssets
Total assets¥5.7bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥539mat 2022-06-30StandaloneLiabilities
Total liabilities¥475mat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.7bnat 2022-06-30StandaloneNet assets
Net assets / equity¥4.9bnat 2021-09-30StandaloneNet assets
Net assets / equity¥5.2bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.8bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥4.1bnat 2021-09-30StandaloneCash and deposits
EPS (basic)¥-5.112021-10-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.52022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.882020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-3.212020-10-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.222021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio91.4%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.2%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued211,730,423at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued178,750,423at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued177,730,423at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥386m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥425m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥178m
—segment totalrevenue2021-10-01 → 2022-06-30¥470m
—segment totalrevenue external2021-10-01 → 2022-06-30¥470m
—segment totalsegment profit2021-10-01 → 2022-06-30−¥603m
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-06-30−¥385m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2020-10-01 → 2021-06-30¥143,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2020-10-01 → 2021-06-30¥143,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2020-10-01 → 2021-06-30−¥319m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2020-10-01 → 2021-06-30¥512m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2020-10-01 → 2021-06-30¥512m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2020-10-01 → 2021-06-30−¥88m
—segment totalrevenue2020-10-01 → 2021-06-30¥512m
—segment totalrevenue external2020-10-01 → 2021-06-30¥512m
—segment totalsegment profit2020-10-01 → 2021-06-30−¥407m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 318
ItemContextValueUnit
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember51867000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember20900000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember17863000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember51007000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember25804000JPY
Asset retirement obligations clPrior1YearInstant_NonConsolidatedMember66000000JPY
Asset retirement obligations clCurrentQuarterInstant_NonConsolidatedMember66000000JPY
Other clPrior1YearInstant_NonConsolidatedMember96215000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember113104000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember275036000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember274639000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember154200000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember155668000JPY
Other nclPrior1YearInstant_NonConsolidatedMember45707000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember108704000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember199908000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember264372000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember474945000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember539012000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember5082073000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember5892020000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember550646000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember1360593000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-843396000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1828284000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember4789323000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember5424329000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember91636000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember301846000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember91636000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember301846000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember21766000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember－JPY
Net assetsPrior1YearInstant_NonConsolidatedMember4902726000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember5726175000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5377672000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember6265188000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember512256000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember469785000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember372140000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember380060000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember140116000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember89725000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember932147000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember1078131000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-792031000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-988406000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5121000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember5075000JPY
Gain on investments in partnership noiPrior1YTDDuration_NonConsolidatedMember209675000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass